Skip to main content
Clinical Trials/IRCT20210831052349N1
IRCT20210831052349N1
Recruiting
Phase 3

Comparison of the effectiveness of anti-anxiety medication (buspirone and sertraline) on anxiety and gastrointestinal symptoms of functional dyspepsia patients

Birjand University of Medical Sciences0 sites141 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Birjand University of Medical Sciences
Enrollment
141
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Willingness to participate in the study after fully explaining the objectives of the research and the disadvantages and advantages of the methods
  • not receiving psychological therapies before entering the study
  • No alcohol and drugs
  • Absence of danger signs such as gastrointestinal bleeding, blood in the stool, fever, weight loss, anemia, nocturnal diarrhea, severe heartburn
  • No psychotic disorder and personality disorder
  • Possibility to keep the type and amount of drug used during the research period if the drug is used
  • No other organic disease
  • Lack of other structural or functional gastrointestinal disorders

Exclusion Criteria

  • Having psychotic disorder or other gastrointestinal disorders
  • Existence of danger signs in the patient (such as gastrointestinal bleeding, blood in the stool, fever, weight loss, anemia, nocturnal diarrhea, severe heartburn, etc.)
  • Having complete criteria for personality disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials